Market Closed -
Deutsche Boerse AG
07:10:22 26/06/2024 BST
|
5-day change
|
1st Jan Change
|
0.01
EUR
|
+122.22%
|
|
-23.08%
|
-41.18%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6.71
|
5.569
|
1.22
|
0.5666
|
Enterprise Value (EV)
1 |
6.713
|
3.703
|
-0.613
|
-2.028
|
P/E ratio
|
-3.39
x
|
-0.88
x
|
-0.17
x
|
0.71
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
5,932,997
x
|
396,928
x
|
-
|
EV / Revenue
|
-
|
3,945,098
x
|
-199,457
x
|
-
|
EV / EBITDA
|
-3,284,471
x
|
-1,251,780
x
|
299,742
x
|
4,065,123
x
|
EV / FCF
|
-8,849,754
x
|
3,197,549,223
x
|
9,417,985
x
|
2,633,282
x
|
FCF Yield
|
-0%
|
0%
|
0%
|
0%
|
Price to Book
|
5.89
x
|
0.97
x
|
1.44
x
|
0.34
x
|
Nbr of stocks (in thousands)
|
2,886
|
10,607
|
16,265
|
16,190
|
Reference price
2 |
2.325
|
0.5250
|
0.0750
|
0.0350
|
Announcement Date
|
30/04/21
|
02/05/22
|
01/05/23
|
16/04/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
0.9386
|
3.073
|
-
|
EBITDA
|
-
|
-2.044
|
-2.958
|
-2.045
|
-0.4989
|
EBIT
1 |
-0.3828
|
-2.069
|
-3.312
|
-2.787
|
-0.4993
|
Operating Margin
|
-
|
-
|
-352.86%
|
-90.7%
|
-
|
Earnings before Tax (EBT)
1 |
-0.3766
|
-2.12
|
-4.544
|
-7.249
|
-0.4631
|
Net income
1 |
-0.3766
|
-2.085
|
-4.531
|
-7.122
|
0.7933
|
Net margin
|
-
|
-
|
-482.7%
|
-231.73%
|
-
|
EPS
2 |
-0.2344
|
-0.6862
|
-0.5962
|
-0.4512
|
0.0490
|
Free Cash Flow
|
-
|
-0.7586
|
0.001158
|
-0.0651
|
-0.7702
|
FCF margin
|
-
|
-
|
0.12%
|
-2.12%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/20
|
30/04/21
|
02/05/22
|
01/05/23
|
16/04/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0
|
-
|
-
|
-
|
Net Cash position
1 |
1.57
|
-
|
1.87
|
1.83
|
2.59
|
Leverage (Debt/EBITDA)
|
-
|
-0.001882
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.76
|
0
|
-0.07
|
-0.77
|
ROE (net income / shareholders' equity)
|
-
|
-151%
|
-132%
|
-217%
|
-35.2%
|
ROA (Net income/ Total Assets)
|
-
|
-72%
|
-45.3%
|
-33.3%
|
-10.8%
|
Assets
1 |
-
|
2.894
|
9.999
|
21.36
|
-7.338
|
Book Value Per Share
2 |
0.6500
|
0.3900
|
0.5400
|
0.0500
|
0.1000
|
Cash Flow per Share
2 |
0.6100
|
0.1400
|
0.2400
|
0.1200
|
0.0400
|
Capex
|
-
|
0.29
|
0
|
-
|
-
|
Capex / Sales
|
-
|
-
|
0.11%
|
-
|
-
|
Announcement Date
|
30/04/20
|
30/04/21
|
02/05/22
|
01/05/23
|
16/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +29.99% | 5.69B | | -31.99% | 3.53B | | -0.59% | 3.06B | | -24.15% | 2.62B | | -9.23% | 2.29B | | +42.55% | 1.86B | | +44.37% | 1.43B | | -11.29% | 1.41B | | +42.86% | 1.4B |
Alternative Medicine
|